Description

Based in South Korea, Ilyang Pharmaceutical Co.,Ltd operates as a significant enterprise within the pharmaceutical sector. The company offers an extensive array of medicinal products designed to address diverse health concerns, including treatments for cancer, circulatory ailments, endocrine and metabolic disorders, specific Cheonjiyang offerings, female hormone regulation, urinary tract issues, ophthalmological conditions, and liver diseases. Its portfolio further extends to digestive and respiratory system therapies, dermatological solutions, anti-inflammatory pain relievers, and neurological medications, alongside nutrient infusions, antibiotics, antifungal agents, insecticides, and vaccines. Beyond pharmaceuticals, Ilyang Pharmaceutical diversifies its product lines to include consumer health goods such as health drinks, daily food items, nutritional supplements, health foods, cosmetics, and various beverages. Moreover, it is a manufacturer of crucial pharmaceutical raw materials, producing a wide range of aluminum and magnesium compounds like aluminum hydroxide gel, magnesium hydroxide, hydrotalcite, magaldrate, and others. Established in 1946 and headquartered in Yongin, South Korea, the company, initially known as Il-Yang Pharm. Ind. Co. before its name change in May 1991, also exports its products to approximately 14 countries globally.